top of page
Executive Spotlights

Inari Acquires LimFlow, a Limb-Saving Device Manufacturer, in a $415M Deal

Irvine, CA, November 3, 2023 ( -- Inari Medical will acquire LimFlow, a company specializing in a device for chronic limb-threatening blood flow loss, for $250 million in cash along with potential milestone payments, in a deal worth $415 million. LimFlow's technology aims to restore oxygenated blood flow to the foot through veins, bypassing blocked leg arteries, in individuals with chronic limb-threatening ischemia (CLTI). This treatment is designed for patients at risk of amputation after exhausting other treatment options.

Read full article here.

Recent Posts

See All

Rahway, NJ & Cambridge, MA, November 21, 2023 (Business Wire) -- Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. declare a definitive agr

Life Science Headlines
bottom of page